Winton Group LTD Adaptive Biotechnologies Corp Transaction History

Winton Group LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $22,175 - $28,742	2,843 Added 12.08%	26,383 $232,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $7,136 - $10,647	1,140 Added 5.09%	23,540 $179,000
Q3 2022 Nov 10, 2022	SELL	$6.5 - $12.67 $13,494 - $26,302	-2,076 Reduced 8.48%	22,400 $159,000
Q2 2022 Aug 10, 2022	BUY	$6.4 - $14.73 $35,820 - $82,443	5,597 Added 29.65%	24,476 $198,000
Q1 2022 May 11, 2022	BUY	$10.12 - $28.9 $36,219 - $103,433	3,579 Added 23.39%	18,879 $262,000
Q4 2021 Feb 10, 2022	BUY	$25.17 - $36.85 $27,762 - $40,645	1,103 Added 7.77%	15,300 $429,000
Q3 2021 Oct 28, 2021	SELL	$30.02 - $39.87 $103,298 - $137,192	-3,441 Reduced 19.51%	14,197 $483,000
Q2 2021 Aug 10, 2021	BUY	$32.22 - $44.59 $20,427 - $28,270	634 Added 3.73%	17,638 $721,000
Q1 2021 Jul 21, 2021	SELL	$37.26 - $67.74 $56,784 - $103,235	-1,524 Reduced 8.23%	17,004 $685,000
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $655,030 - $952,784	-14,553 Reduced 43.99%	18,528 $1.1 Million
Q3 2020 Oct 30, 2020	BUY	$35.79 - $48.81 $1.18 Million - $1.61 Million	33,081 New	33,081 $1.61 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.